Dr Agarwal'S Eye Hospital (BOM:526783) Cyclically Adjusted Revenue per Share: ₹638.15 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:526783 Dr Agarwal'S Eye Hospital Ltd BOM:526783
94 GF Score
Price ₹5,405.25
GF Value ₹5,458.21
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dr Agarwal'S Eye Hospital Cyclically Adjusted Revenue per Share?

Dr Agarwal'S Eye Hospital BOM:526783 -1.22% 94 Cyclically Adjusted Revenue per Share is ₹638.15 as of Jun. 2026. GuruFocus rates BOM:526783 with a GF Score™ of 94/100 and a GF Value™ of ₹5,458.21 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Dr Agarwal'S Eye Hospital's adjusted revenue per share for the three months ended in Jun. 2026 was ₹295.820. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹638.15 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Dr Agarwal'S Eye Hospital's average Cyclically Adjusted Revenue Growth Rate was 14.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 12.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Dr Agarwal'S Eye Hospital was 12.10% per year. The lowest was 8.30% per year. And the median was 10.60% per year.

As of today (2026-08-15), Dr Agarwal'S Eye Hospital's current stock price is ₹5405.25. Dr Agarwal'S Eye Hospital's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹638.15. Dr Agarwal'S Eye Hospital's Cyclically Adjusted PS Ratio of today is 8.47.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Dr Agarwal'S Eye Hospital was 13.09. The lowest was 0.60. And the median was 3.49.


Dr Agarwal'S Eye Hospital  (BOM:526783) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Dr Agarwal'S Eye Hospital's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=5405.25/638.15
=8.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Dr Agarwal'S Eye Hospital was 13.09. The lowest was 0.60. And the median was 3.49.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Dr Agarwal'S Eye Hospital Cyclically Adjusted Revenue per Share Related Terms


Dr Agarwal'S Eye Hospital Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Dr Agarwal'S Eye Hospital's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Agarwal'S Eye Hospital Cyclically Adjusted Revenue per Share Chart

Dr Agarwal'S Eye Hospital Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 397.75 436.16 480.62 538.24 614.36

Dr Agarwal'S Eye Hospital Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 558.42 579.87 597.91 614.36 638.15

BOM:526783 vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Dr Agarwal'S Eye Hospital's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Agarwal'S Eye Hospital Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dr Agarwal'S Eye Hospital's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Dr Agarwal'S Eye Hospital's Cyclically Adjusted PS Ratio falls into.


BOM:526783
94GF Score
Dr Agarwal'S Eye Hospital Ltd BOM:526783
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr Agarwal'S Eye Hospital Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dr Agarwal'S Eye Hospital's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=295.82/167.3573*167.3573
=295.820

Current CPI (Jun. 2026) = 167.3573.

Dr Agarwal'S Eye Hospital Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 83.601 105.961 132.041
201612 74.052 105.196 117.810
201703 78.058 105.196 124.183
201706 88.988 107.109 139.044
201709 83.583 109.021 128.307
201712 73.743 109.404 112.806
201803 79.770 109.786 121.601
201806 94.467 111.317 142.025
201809 93.491 115.142 135.888
201812 86.524 115.142 125.762
201903 85.938 118.202 121.676
201906 98.945 120.880 136.989
201909 96.898 123.175 131.655
201912 92.786 126.235 123.012
202003 84.267 124.705 113.088
202006 31.949 127.000 42.101
202009 64.559 130.118 83.036
202012 90.929 130.889 116.264
202103 109.503 131.771 139.076
202106 65.976 134.084 82.348
202109 123.751 135.847 152.456
202112 120.170 138.161 145.565
202203 117.872 138.822 142.101
202206 147.287 142.347 173.165
202209 146.308 144.661 169.263
202212 135.249 145.763 155.286
202303 144.756 146.865 164.954
202306 167.092 150.280 186.080
202309 178.915 151.492 197.652
202312 161.630 152.924 176.885
202403 165.816 153.035 181.335
202406 212.809 155.789 228.612
202409 217.472 157.882 230.523
202412 202.362 158.323 213.909
202503 212.404 157.552 225.623
202506 248.766 159.755 260.604
202509 250.042 162.289 257.851
202512 240.522 163.281 246.527
202603 248.314 164.272 252.977
202606 295.820 167.357 295.820

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹638.15 mean?
Dr Agarwal'S Eye Hospital (BOM:526783) has a Cyclically Adjusted Revenue per Share of ₹638.15 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Dr Agarwal'S Eye Hospital and its competitors.
Is Dr Agarwal'S Eye Hospital's Cyclically Adjusted Revenue per Share too high?
Dr Agarwal'S Eye Hospital's current Cyclically Adjusted Revenue per Share is ₹638.15. Overall, Dr Agarwal'S Eye Hospital has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal'S Eye Hospital's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Dr Agarwal'S Eye Hospital's Cyclically Adjusted Revenue per Share of ₹638.15 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Dr Agarwal'S Eye Hospital and its competitors. Dr Agarwal'S Eye Hospital's current Cyclically Adjusted Revenue per Share is ₹638.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal'S Eye Hospital stock overvalued right now?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital (BOM:526783) is currently considered Fairly Valued. The stock's GF Value™ is ₹5,458.21, compared to a current price of ₹5,405.25 — trading 1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹638.15. Dr Agarwal'S Eye Hospital's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Dr Agarwal'S Eye Hospital (BOM:526783), the current Cyclically Adjusted Revenue per Share is ₹638.15 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr Agarwal'S Eye Hospital (BOM:526783) Overvalued in 2026?

Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital stock appears to be undervalued. The current stock price of ₹5,405.25 is trading 1% below its estimated GF Value™ of ₹5,458.21. GuruFocus considers Dr Agarwal'S Eye Hospital to be Fairly Valued.

Key valuation signals for BOM:526783:

  • Cyclically Adjusted Revenue per Share: ₹638.15
  • GF Value™: ₹5,458.21 vs. price of ₹5,405.25 (1% below fair value)
  • GF Score™: 94/100 with 3 warning signs

No single metric tells the full story. See the BOM:526783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr Agarwal'S Eye Hospital Business Description

Address No. 4, Moores Road, Off Greams Road, 3rd Floor, Buhari Towers, Chennai, TN, IND, 600 006
Dr Agarwal'S Eye Hospital Ltd is a provider of eye care and related services. The company is predominantly engaged in running, owning and managing eye care hospitals, opticals, pharmacies, and related services. It operates across various locations in India and provides solutions like Refractive Surgery, Lasik Surgery, Oculoplasty, Laser Cataract Surgery, and SMILE Eye Surgery among others.
94GF Score

Get the complete analysis for BOM:526783

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5,405.25
Price
₹5,458.21
GF Value